Literature DB >> 23821517

Draft genome sequences of five recent human uropathogenic Escherichia coli isolates.

Sargurunathan Subashchandrabose1, Tracy H Hazen2, David A Rasko2, Harry L T Mobley3.   

Abstract

This study reports the release of draft genome sequences of five isolates of uropathogenic Escherichia coli (UPEC), isolated from patients suffering from uncomplicated cystitis in 2012 in Ann Arbor, Michigan. Phylogenetic analyses revealed that these strains belonged to E. coli phylogroups B2 and D and are closely related to known UPEC strains. Comparative genomic analysis revealed that more conserved proteins were shared between these recent isolates and UPEC strains causing cystitis than those causing pyelonephritis. Additional genomic comparisons identified that three isolates encode a type III secretion system (T3SS) and a putative T3SS effector gene cluster along with an invasin-like outer membrane protein. The presence of T3SS genes is a rare occurrence among UPEC strains. These genomes further substantiate the heterogeneity of the gene pool of UPEC and provide a foundation for comparative genomic studies using recent clinical isolates.
© 2013 Federation of European Microbiological Societies.

Entities:  

Keywords:  draft genomes; type III secretion system; uropathogenic Escherichia coli

Mesh:

Substances:

Year:  2013        PMID: 23821517      PMCID: PMC3843978          DOI: 10.1111/2049-632X.12059

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  28 in total

1.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

2.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

3.  A degenerate type III secretion system from septicemic Escherichia coli contributes to pathogenesis.

Authors:  Diana Ideses; Uri Gophna; Yossi Paitan; Roy R Chaudhuri; Mark J Pallen; Eliora Z Ron
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

Review 4.  Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.

Authors:  Alexander R C Wong; Jaclyn S Pearson; Michael D Bright; Diana Munera; Keith S Robinson; Sau Fung Lee; Gad Frankel; Elizabeth L Hartland
Journal:  Mol Microbiol       Date:  2011-05-05       Impact factor: 3.501

Review 5.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

6.  How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains.

Authors:  Elzbieta Brzuszkiewicz; Holger Brüggemann; Heiko Liesegang; Melanie Emmerth; Tobias Olschläger; Gábor Nagy; Kaj Albermann; Christian Wagner; Carmen Buchrieser; Levente Emody; Gerhard Gottschalk; Jörg Hacker; Ulrich Dobrindt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-15       Impact factor: 11.205

7.  Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.

Authors:  Amanda L Lloyd; David A Rasko; Harry L T Mobley
Journal:  J Bacteriol       Date:  2007-03-09       Impact factor: 3.490

8.  Genomic islands of uropathogenic Escherichia coli contribute to virulence.

Authors:  Amanda L Lloyd; Tiffany A Henderson; Patrick D Vigil; Harry L T Mobley
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

9.  Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota.

Authors:  Janelle S Ayres; Norver J Trinidad; Russell E Vance
Journal:  Nat Med       Date:  2012-05       Impact factor: 53.440

10.  Escherichia coli global gene expression in urine from women with urinary tract infection.

Authors:  Erin C Hagan; Amanda L Lloyd; David A Rasko; Gary J Faerber; Harry L T Mobley
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

View more
  12 in total

1.  Blocking yersiniabactin import attenuates extraintestinal pathogenic Escherichia coli in cystitis and pyelonephritis and represents a novel target to prevent urinary tract infection.

Authors:  Ariel R Brumbaugh; Sara N Smith; Sargurunathan Subashchandrabose; Stephanie D Himpsl; Tracy H Hazen; David A Rasko; Harry L T Mobley
Journal:  Infect Immun       Date:  2015-01-26       Impact factor: 3.441

2.  Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection.

Authors:  Laura A Mike; Sara N Smith; Christopher A Sumner; Kathryn A Eaton; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-07       Impact factor: 11.205

Review 3.  Virulence and Fitness Determinants of Uropathogenic Escherichia coli.

Authors:  Sargurunathan Subashchandrabose; Harry L T Mobley
Journal:  Microbiol Spectr       Date:  2015-08

Review 4.  Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection.

Authors:  Sargurunathan Subashchandrabose; Harry L T Mobley
Journal:  Metallomics       Date:  2015-06       Impact factor: 4.526

5.  Host-specific induction of Escherichia coli fitness genes during human urinary tract infection.

Authors:  Sargurunathan Subashchandrabose; Tracy H Hazen; Ariel R Brumbaugh; Stephanie D Himpsl; Sara N Smith; Robert D Ernst; David A Rasko; Harry L T Mobley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

6.  Transcriptional Alterations of Virulence-Associated Genes in Extended Spectrum Beta-Lactamase (ESBL)-Producing Uropathogenic Escherichia coli during Morphologic Transitions Induced by Ineffective Antibiotics.

Authors:  Isak Demirel; Ignacio Rangel; Ulrika Petersson; Katarina Persson; Robert Kruse
Journal:  Front Microbiol       Date:  2017-06-13       Impact factor: 5.640

7.  Rapid Growth of Uropathogenic Escherichia coli during Human Urinary Tract Infection.

Authors:  Valerie S Forsyth; Chelsie E Armbruster; Sara N Smith; Ali Pirani; A Cody Springman; Matthew S Walters; Greta R Nielubowicz; Stephanie D Himpsl; Evan S Snitkin; Harry L T Mobley
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

Review 8.  The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.

Authors:  John R Brannon; Maria Hadjifrangiskou
Journal:  Drug Des Devel Ther       Date:  2016-05-27       Impact factor: 4.162

9.  An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study.

Authors:  Flor Y Ramírez-Castillo; Adriana C Moreno-Flores; Francisco J Avelar-González; Francisco Márquez-Díaz; Josée Harel; Alma L Guerrero-Barrera
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-07-24       Impact factor: 3.944

10.  Cross Talk between MarR-Like Transcription Factors Coordinates the Regulation of Motility in Uropathogenic Escherichia coli.

Authors:  Courtney L Luterbach; Harry L T Mobley
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.